FLOWPTIDES-2 TRZ is a research-grade synthetic peptide supplied as a lyophilized powder for use in controlled laboratory settings. This compound is a dual glucose-dependent insulinotropic polypeptide (GIP) and incretin receptor agonist that has been the subject of significant scientific inquiry in the field of metabolic pathway research. Structurally, FLOWPTIDES-2 TRZ is a 39-amino acid linear peptide incorporating a C20 fatty diacid moiety conjugated via a linker to a lysine residue, enabling prolonged activity in experimental systems through non-covalent albumin association within assay media.
In cell-based reporter assays, FLOWPTIDES-2 TRZ has demonstrated potent agonism at both GIP and incretin receptor subtypes, allowing researchers to investigate the consequences of simultaneous dual-receptor engagement on intracellular signaling cascades, including cAMP generation, beta-arrestin recruitment, and ERK phosphorylation dynamics. The 10 mg presentation is well suited for investigators initiating studies, establishing binding curves, or conducting preliminary dose-finding experiments in cellular models of pancreatic islet biology, hypothalamic neurocircuitry, and adipocyte differentiation.
Each vial from Flowptides Peptides is accompanied by analytical data confirming sequence identity via mass spectrometry and purity via reverse-phase HPLC. This product is sold exclusively for research purposes and is not intended for human or veterinary consumption under any circumstances. All laboratory personnel handling this compound should observe standard safety protocols.
FDA DISCLAIMER
The information provided on this website has not been evaluated by the U.S. Food and Drug Administration (FDA). None of the statements herein, nor any of the products offered, are intended to diagnose, treat, cure, or prevent any medical condition.
All products are supplied strictly as laboratory research reagents and are not for human consumption. We do not provide products to patients and do not make any claims regarding medical use.
Flowptides Peptides operates solely as a chemical supplier. It is not a compounding pharmacy and does not operate as a compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act.
Reviews
There are no reviews yet.